Shanghai Henlius Biotech, Inc. (HKG: 2696)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
20.15
-0.10 (-0.49%)
Nov 15, 2024, 4:08 PM HKT

Shanghai Henlius Biotech Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
10,9517,5556,95711,98425,51722,147
Upgrade
Market Cap Growth
105.86%8.59%-41.95%-53.04%15.21%-
Upgrade
Enterprise Value
14,59211,11210,23313,63525,01122,671
Upgrade
Last Close Price
20.1513.9012.8022.0546.9540.75
Upgrade
PE Ratio
14.7712.62----
Upgrade
Forward PE
17.0112.55----
Upgrade
PS Ratio
1.811.271.915.8036.57217.73
Upgrade
PB Ratio
3.953.133.764.256.724.95
Upgrade
P/TBV Ratio
---25.8712.465.50
Upgrade
P/FCF Ratio
16.2011.9415.51---
Upgrade
P/OCF Ratio
11.966.546.27108.01--
Upgrade
EV/Sales Ratio
2.411.872.826.6035.84222.88
Upgrade
EV/EBITDA Ratio
11.7111.07----
Upgrade
EV/EBIT Ratio
17.0615.97----
Upgrade
EV/FCF Ratio
21.5817.5722.82---
Upgrade
Debt / Equity Ratio
1.571.872.251.140.570.15
Upgrade
Debt / EBITDA Ratio
3.504.16----
Upgrade
Debt / FCF Ratio
6.447.139.27---
Upgrade
Asset Turnover
0.580.570.400.250.100.02
Upgrade
Inventory Turnover
1.901.951.431.440.840.93
Upgrade
Quick Ratio
0.300.340.270.350.672.46
Upgrade
Current Ratio
0.490.530.440.560.962.77
Upgrade
Return on Equity (ROE)
30.99%28.52%-35.35%-35.81%-27.60%-30.17%
Upgrade
Return on Assets (ROA)
5.08%4.19%-4.88%-6.11%-9.37%-11.25%
Upgrade
Return on Capital (ROIC)
7.99%6.81%-7.68%-8.36%-11.99%-14.57%
Upgrade
Earnings Yield
5.99%7.96%-11.30%-10.08%-4.62%-4.42%
Upgrade
FCF Yield
5.44%8.37%6.45%-3.79%-5.43%-3.70%
Upgrade
Buyback Yield / Dilution
-0.11%-0.25%-0.59%-1.75%-6.52%-16.54%
Upgrade
Total Shareholder Return
-0.11%-0.25%-0.59%-1.75%-6.52%-16.54%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.